SCHEMBL30468997

SCHEMBL30468997

NC(=O)C1(C(N)=O)CCC1CCCCCNC(=O)CN1C(=O)C=CC1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TPSAB1 Q15661 3/20 0.34
▸ TSHR P16473 3/20 0.34
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC2 Q92769 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HDAC9 Q9UKV0 1/20 0.33
▸ HDAC5 Q9UQL6 1/20 0.33
▸ PPID Q08752 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CA12 O43570 4/20 0.32
▸ CA1 P00915 4/20 0.32
▸ CA2 P00918 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30469018 0.78 HDAC3 (0.31) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL21518572 0.75 PTGS1 (0.42) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL30469008 0.74 PTGS1 (0.32) MAPTSMN1; SMN2
SCHEMBL31087111 0.73 PAOX (0.44) TPSAB1KDM4EMEN1MAPTPABPC1
SCHEMBL30469016 0.68 HTR1A (0.30) CYP2C19
SCHEMBL19708893 0.68 MAPT (0.36) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL17841861 0.67 GSK3A (0.41) TSHRPPIDCYP1A2CYP2C19CA1
SCHEMBL18165064 0.67 HDAC1 (0.41) TSHRHDAC1HDAC2HDAC3HDAC4
SCHEMBL30396758 0.66 PTGS1 (0.53) TSHRMEN1MAPTKMT2A
SCHEMBL25704170 0.65 ALDH1A1 (0.47) CYP1A2CYP2C19KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469090-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION WITH HYDOLYSABLE MALEIMIDE LINKERS AND METHODS THEREOF Genentech Inc. (US) 2024-12-04 — — EP disclosed
WO-2023147328-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION WITH HYDOLYSABLE MALEIMIDE LINKERS AND METHODS THEREOF GENENTECH, INC. (US) 2023-08-03 — — WO disclosed
Send feedback